You are in a "view as others" mode
Overview
NEXT GENERATION IMMUNOTHERAPIES FOR IMMUNE DISORDERS
Description
Allero Therapeutics is a Dutch, venture-backed, biopharmaceutical company that develops next generation immunotherapies for immune mediated disorders. Our goal is to develop novel targeted treatments that induce long-lasting antigen-specific tolerance.
Our proprietary SOMIT (Specific Oromucosal Immunotherapy) technology combines a tolerance-inducing agent with novel oral patch mediated targeted delivery of specific antigens to the oral mucosa immune privilege.
Founded 2016
2-10
Categories
Products
Looks like Allero Therapeutics has no published products yet.
Services
Looks like Allero Therapeutics has no published services yet.
Company reviews
Profile Strength:
undefined%
profile
completion